CDW · CDW Corporation

The thesis

CDW Corporation's shares closed at $161.41 on 27 October 2026, above the $156.19 high cited in the previous note, but no new company result has shown that record second-quarter sales are turning into better gross margin or cash flow. The third-quarter report on 4 November 2026 settles whether gross margin holds at or above 20.1% and free cash flow turns positive.

The narrative is maturing into the print: the Lovelytics deal closed on 25 September 2026, the shares have since moved to a 52-week high of $165.11 (adjusted daily closes), and the next dated company event is the earnings call. The 14-day relative strength index (RSI) is 78.3 on 27 October 2026, a reading above 70 that marks a fast run-up. The three-month price change is 11.4%.

The last results were strong on sales and weak on conversion. Gross margin fell to 20.1% from 20.8% a year earlier, and free cash flow was negative $251.4 million (CDW release and earnings call, 5 August 2026).

Two items are new since the 15 October 2026 note. CDW confirmed on 21 October 2026 that it will report on Wednesday, 4 November 2026, with a webcast at 8:30 a.m. ET. Northcoast Research raised its price target to $171 from $167 on 23 October 2026.

Bullish and bearish views on CDW Corporation

The bull case on CDW Corporation (CDW), in brief: Sales and earnings beat. The bear case: Margins trail revenue.

Bull case

• Sales and earnings beat. Second-quarter net sales of $6.572 billion beat the $6.206 billion consensus, and non-GAAP earnings per share of $2.91 beat the $2.80 estimate (CDW release, 5 August 2026).
• Analyst targets are moving up. Northcoast Research raised its target to $171 from $167 on 23 October 2026, and Morgan Stanley's Overweight rating carries a $171 target set on 6 August 2026. Both sit above the 27 October 2026 close of $161.41.
• Services build-out is complete. CDW closed the roughly $525 million Lovelytics purchase on 25 September 2026 (company press release via Business Wire). The data and AI consultancy adds more than 600 staff.
• Price has confirmed the recovery. The shares closed at $135.83 on 1 October 2026 and $161.41 on 27 October 2026, and the 52-week high is now $165.11, 2.2% above the last close (adjusted daily closes).

Bear case

• Margins trail revenue. Gross margin was 21.6%, 21.0% and 20.1% across the last three comparable reports. Management attributed the second-quarter drop to product mix (5 August 2026 earnings call).
• Cash flow turned negative. Free cash flow was negative $251.4 million in the second quarter, against positive $210.1 million a year earlier (StockStory summary, 5 August 2026).
• New debt is in the numbers. CDW announced a $1.5 billion senior-notes financing in September to redeem existing notes and part-fund Lovelytics, and the shares fell 4.6% to $139.46 that day (Quiver Quant, 24 September 2026).
• Price is stretched into the report. An RSI of 78.3 on 27 October 2026, eight days before earnings, leaves little room for a margin miss. Barclays kept Equal-Weight with a $148 target on 21 September 2026, which is below the last close.
• CFO succession is open. Albert J. Miralles said on 5 August 2026 that he plans to retire in 2027, and no successor had been named at that date.

Price setup

The shares closed at $161.41 on 27 October 2026, 2.2% below the 52-week high of $165.11. The close on 14 October 2026 was $150.10, and the August 2026 post-earnings low was $129.13. The 24 September 2026 close of $139.46, after the notes announcement, is the nearest recent low.

The RSI of 78.3 shows buying has been strong and rapid. Heavy retail attention is not measured in any source reviewed. No SEC Form 4 insider sales or share issuance into the rally were found in recent filings, and the September debt offering is the only recent capital-markets event.

The earnings date is the main crowding fact: the shares are priced near their high with the report eight days away. The previous note flagged a 3 November 2026 estimate. CDW's own 21 October 2026 release moves it to 4 November 2026.

Catalysts, next 30 days

• Following days, analyst target changes. Northcoast ($171) and Morgan Stanley ($171) have set targets near the current price. Barclays ($148) sits below it. Post-report revisions show whether the move holds.

Elapsed catalysts

• 4 November 2026, Q3 2026 results and call (8:30 a.m. ET). CDW's release confirmed the date on 21 October 2026. The report shows gross margin against 20.1%, free cash flow against the negative $251.4 million in Q2, and net sales against the cautious sequential guide given on 5 August 2026. (passed 2d ago)

What would change the view

The case breaks if third-quarter gross margin falls below 20.1%, if free cash flow is negative for a second straight quarter, or if full-year gross-margin guidance is widened below "modestly below FY25". Net sales under the mid-single-digit sequential decline implied by the 5 August 2026 guide would show demand softening.

In price terms, a weekly close below $139 would put the shares under the 24 September 2026 close of $139.46 and erase the October rally. A target cut by Morgan Stanley or Northcoast from $171 would also weaken the analyst support.

Conviction stays low. The price and target moves since 15 October 2026 are not company results, and the evidence on margin and cash flow is unchanged until 4 November 2026.

What it trades with

CDW resells hardware, software and services to businesses and governments, so its sales track US corporate IT budgets more than any single AI product cycle.

Netted-down (agency) accounting was 35.9% of Q2 2026 gross profit, so shifts in mix affect reported net sales growth. Large PC, server and software vendors report on their own calendars and move CDW's volumes. No company filings were posted in the recent filing feed.